107 related articles for article (PubMed ID: 23348175)
1. Types of HLA in the bladder transitional cell carcinoma (TCC).
Yılmaz E; Uğur Özalp A; Cekmen A; Eren B; Onal B; Akkuş E; Erdoğan E
Med Glas (Zenica); 2013 Feb; 10(1):133-6. PubMed ID: 23348175
[TBL] [Abstract][Full Text] [Related]
2. Tumor-specific upregulation of human leukocyte antigen-G expression in bladder transitional cell carcinoma.
Gan LH; Huang LF; Zhang X; Lin A; Xu DP; Wang Q; Wang TJ; Yan WH
Hum Immunol; 2010 Sep; 71(9):899-904. PubMed ID: 20600448
[TBL] [Abstract][Full Text] [Related]
3. HLA-antigens in black patients with hepatocellular carcinoma.
Maharaj B; Khedun SM; Hammond MG
East Afr Med J; 1997 Nov; 74(11):705-7. PubMed ID: 9557441
[TBL] [Abstract][Full Text] [Related]
4. Reduction of major histocompatibility complex class I antigens on invasive and high-grade transitional cell carcinoma.
Tomita Y; Matsumoto Y; Nishiyama T; Fujiwara M
J Pathol; 1990 Oct; 162(2):157-64. PubMed ID: 2250194
[TBL] [Abstract][Full Text] [Related]
5. HLA-A, B and DR in Caucasians with transitional cell carcinoma of the bladder.
Saunders PH; Anderson SA; Stogdill VD; Lamm DL
Tissue Antigens; 1983 Nov; 22(5):389-92. PubMed ID: 6581580
[TBL] [Abstract][Full Text] [Related]
6. Human leukocyte antigens in Turkish pediatric celiac patients.
Erkan T; Kutlu T; Yilmaz E; Cullu F; Tümay GT
Turk J Pediatr; 1999; 41(2):181-8. PubMed ID: 10770656
[TBL] [Abstract][Full Text] [Related]
7. HLA-DR antigen expression and lymphocyte subsets in transitional cell carcinoma of the urinary bladder. An immunohistological study on frozen sections.
Ioachim-Velogianni E; Stavropoulos NE; Kitsiou E; Stefanaki S; Agnantis NJ
J Pathol; 1994 Nov; 174(3):183-9. PubMed ID: 7823251
[TBL] [Abstract][Full Text] [Related]
8. HLA antigens and inflammatory bowel disease in a sample of Iraqi patients.
Adhiah AH; Jasim HA; Fadhil AM
East Mediterr Health J; 2008; 14(5):1155-63. PubMed ID: 19161089
[TBL] [Abstract][Full Text] [Related]
9. Selective and non-selective loss of immunoregulatory molecules (HLA-A,B,C antigens and LFA-3) in transitional cell carcinoma.
Nouri AM; Smith ME; Crosby D; Oliver RT
Br J Cancer; 1990 Oct; 62(4):603-6. PubMed ID: 1699592
[TBL] [Abstract][Full Text] [Related]
10. Association between HLA antigens and bladder tumors.
Tokuç R; Akdaş A; Ozerkan K; Remzi D
Eur Urol; 1987; 13(3):207-9. PubMed ID: 3497040
[TBL] [Abstract][Full Text] [Related]
11. Age-dependent association of HLA-A24 in Japanese IDDM patients.
Mizota M; Uchigata Y; Moriyama S; Tokunaga K; Matsuura N; Miura J; Juji T; Omori Y
Diabetologia; 1996 Mar; 39(3):371-3. PubMed ID: 8721789
[No Abstract] [Full Text] [Related]
12. Evaluation of urinary bladder cancer antigen as a marker for diagnosis of transitional cell carcinoma of the urinary bladder.
Heicappell R; Schostak M; Müller M; Miller K
Scand J Clin Lab Invest; 2000 Jul; 60(4):275-82. PubMed ID: 10943597
[TBL] [Abstract][Full Text] [Related]
13. Blood group H antigen in transitional carcinoma of the urinary bladder.
Tichý M; Tichá V; Jansa P; Student V; Vanák J
Acta Univ Palacki Olomuc Fac Med; 1991; 130():157-62. PubMed ID: 1838863
[TBL] [Abstract][Full Text] [Related]
14. Association between Human Leukocyte Antigens (HLA-A, -B, and -DR) and end-stage renal disease in Kuwaiti patients awaiting transplantation.
Mosaad YM; Mansour M; Al-Muzairai I; Al-Otabi T; Abdul-Moneam M; Al-Attiyah R; Shahin M
Ren Fail; 2014 Sep; 36(8):1317-21. PubMed ID: 25010329
[TBL] [Abstract][Full Text] [Related]
15. The comparison between human leukocyte antigen system incidence in patients with bladder cancer and normal controls.
Falahatkar S; Donyamali H; Joafshani MA; Shahrokhi Damavand R; Hoda S; Esmaeili S; Gholamjani Moghaddam K; Nikpour S
Urol J; 2014 Jan; 10(4):1059-62. PubMed ID: 24469650
[TBL] [Abstract][Full Text] [Related]
16. Changes of phenotypic expression of prostatic antigen in secondary transitional cell carcinoma of the prostate: evidence for induction phenomenon as a mechanism for acquisition of prostatic antigens in prostatic transitional cell carcinoma.
Mai KT; Yazdi HM; Farmer J
Prostate; 2001 May; 47(3):172-82. PubMed ID: 11351346
[TBL] [Abstract][Full Text] [Related]
17. Expression of cytokeratin 20 in urinary cytology of patients with bladder carcinoma.
Klein A; Zemer R; Buchumensky V; Klaper R; Nissenkorn I
Cancer; 1998 Jan; 82(2):349-54. PubMed ID: 9445193
[TBL] [Abstract][Full Text] [Related]
18. The relationship between human leukocyte antigens (HLA) and renal cell carcinoma.
Yilmaz E; Çekmen A; Akkuş E; Önal B; Özalp AU; Solok V; Erdoğan E; Eren B
Bosn J Basic Med Sci; 2010 Nov; 10(4):282-6. PubMed ID: 21108609
[TBL] [Abstract][Full Text] [Related]
19. Plasma osteopontin levels are predictive of disease stage in patients with transitional cell carcinoma of the bladder.
Ang C; Chambers AF; Tuck AB; Winquist E; Izawa JI
BJU Int; 2005 Oct; 96(6):803-5. PubMed ID: 16153205
[TBL] [Abstract][Full Text] [Related]
20. CA19.9 and CEA in transitional cell carcinoma of the bladder: serological and immunohistochemical findings.
Hegele A; Mecklenburg V; Varga Z; Olbert P; Hofmann R; Barth P
Anticancer Res; 2010 Dec; 30(12):5195-200. PubMed ID: 21187512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
